By way of the craftiest of PR snakes, pharmaceutical companies infest the media, politicians, and consumers with the idea that if we expressly permit people to buy lower-cost medications from other countries, we break the “closed” pharmaceutical distribution system. This concept of a “closed” system is sadly overplayed and misleading.
The U.S. Food and Drug Administration (FDA) is one of the leading drug regulatory authorities, but as the pharmaceutical industry continues its propagandistic efforts against legalizing importation of lower-cost medication, the myth making has got to be called out. You’ll have to forgive me for the lengthy post: I’ve chosen to include long quotes from experts—perhaps to offset my frustrated tone—but mostly to properly inform you what we’re up against.
The fact is, you can trust the safety and efficacy of medications sold in the U.S., but NOT more so than Canada or many other countries. People are not paying attention to the perpetual lies Big Pharma regurgitates on this issue. In a follow-up post, I’m going to discuss myriad ways that the FDA is doing a much better job, but, for the moment, excuse me while I blow off sufficient “What-the-hell-is-going-on?!” steam. (more…)
Tagged with: closed, coukell, drug distribution, FDA inspections, GAO
For the past three months or so, we’ve published a section a week of our report called “Online Pharmacies, Personal Drug Importation and Public Health.” The report was written to call attention to a woefully flawed and highly misleading report published by the Government Accountability Office about Internet pharmacies and how best to carry out enforcement actions to protect consumers from rogue online pharmacies. Rogue pharmacy websites that endanger public health require serious efforts by regulators and law enforcement personnel, domestically and globally. However, instead of focusing all efforts on the tens of thousands of rouge pharmacy websites polluting the Internet, the federal government and private industry are also targeting the safest international online pharmacies, ones that Americans rely on to obtain affordable medication. Why?
Through this series on our blog, we’ve tried to draw the attention and understanding of our elected leaders and the public-at-large to the fact that the pharmaceutical industry, along with U.S. chain pharmacies, are clearly the ones driving policy, including enforcement priorities when it comes to the issue of online access to safe and affordable medication. In some cases, drug companies are directly funding law enforcement officials. And those companies don’t want Americans obtaining much more affordable and safe medication from pharmacies outside the U.S. And with that, we publish the conclusion to our report.
Tagged with: chain pharmacies, GAO, Government Accountability Office, pharmaceutical industry, public health, rogue online pharmacies
Tens of millions of Americans cannot afford medication, which can lead to more sickness, hospitalizations, and even death. Despite this public health crisis, our trusted regulatory authorities, the pharmaceutical industry, and U.S. pharmacy trade groups work together to scare Americans away from ordering much more affordable medications from foreign pharmacies. Is that right or wrong?
This week, in our continuing quest to get the truth out and for our elected leaders in Congress to take bold action to protect online access to safe and affordable medication, we’re publishing the next section of our report called Online Pharmacies, Personal Drug Importation, and Public Health…
Tagged with: BeSafeRx, Canadian Internet pharmacies, FDA, GAO, ICANN, NBAP, safe online pharmacies